Skip to main content

Table 1 Immunohistochemical results for 4 cases

From: Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary

Patient id

Original IHC results

New IHC results

Cancer Origin Test™results

Lung Cancer Test™results

Clinical Dx prior to new IHC

Results (Final Clinical Dx)

12432

CK7(+), CK8(+), CK19(+), CA125(+), PR (+), CK20(-), CEA(-), TTF1(-), CA19-9(-), VIMENTIN(-)

CK5/6(+, focally), MESOTHELIN(+), CALRETININ(+), EMA(-), LEUM1(-)

Pleural mesothelioma

 

peritoneal ovarian carcinoma

Peritoneal mesothelioma

12412

none performed

CK 7(+), CK20(-), CA125(+), ER(-), PR(-), CEA(-), p63(-)

Ovarian carcinoma

 

SCC of the Head & Neck of skin

Ovary peritoneal caricnoma

11826

none performed

CK7 (+), ER(-), PR(-),GCDFP15(-), S-100(-)(rare cells with only weak cytoplasmic immunoreactivity, therefore this staining was considered negative), CEA(-), EMA(+), p63(-), 34E12(+)

Breast carcinoma or SCC of the Anus or Skin

 

Lung adenocarcinoma or pancreatic adenocarcinoma

Lung adenocarcinoma or pancreatic adenocarcinoma

11805

CK positive and Vimentin negative

TTF1(+), CK7(+, focally), CK20(-), CHROMOGRANIN(+), SYNAPTOPHYSIN(+), CK13(-), CK14(-), CD56(+)

Lung small cell carcinoma or lung adenocarcinoma

Lung small cell carcinoma

Lung adenocarcinoma or pancreatic adenocarcinoma

Lung small cell carcinoma